Effect of Saccharomyces Cerevisiae on the Symptoms of Irritable Bowel Syndrome

Not Applicable

Completed

• Conditions: Irritable Bowel Syndrome
• Interventions: Dietary Supplement: Placebo; Dietary Supplement: Saccharomyces cerevisiae CNCM I-3856

• Registration Number: NCT01613456
• Lead Sponsor: Lesaffre International

Brief Summary

The main purpose of this study is the effect of the probiotic yeast Saccharomyces cerevisiae CNCM I-3856 on abdominal pain or intestinal discomfort in patients presenting with the irritable bowel syndrome (IBS)

Detailed Description

Not available

Study Timeline

• Study Start: 2011-12
• Study First Submitted: 2012-06-05
• Study First Submitted QC: 2012-06-06
• Study First Posted: 2012-06-07
• Primary Completion: 2013-06
• Study Completion: 2013-06
• Status Verified: 2015-05
• Last Update Submitted: 2015-05-13
• Last Update Posted: 2015-05-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 364

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Placebo	Placebo	Dicalcium phosphate, Maltodextrin and Magnesium stearate.
Saccharomyces cerevisiae CNCM I-3856	Saccharomyces cerevisiae CNCM I-3856	-

Primary Outcome Measures

Name	Time	Method
Change from baseline in discomfort score,obtained by Daily Likert Scale averaged by week	baseline and week 8

Trial Locations

Locations (1)

Biofortis; 🇫🇷 Saint Herblain, France